Compare CTAS & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTAS | MDT |
|---|---|---|
| Founded | 1968 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.7B | 131.9B |
| IPO Year | 1994 | 2014 |
| Metric | CTAS | MDT |
|---|---|---|
| Price | $175.96 | $88.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 20 |
| Target Price | ★ $218.91 | $109.89 |
| AVG Volume (30 Days) | 2.4M | ★ 7.0M |
| Earning Date | 03-25-2026 | 02-17-2026 |
| Dividend Yield | 1.02% | ★ 3.23% |
| EPS Growth | N/A | ★ 30.80 |
| EPS | ★ 3.65 | 2.76 |
| Revenue | $6,892,303,000.00 | ★ $33,537,000,000.00 |
| Revenue This Year | $10.73 | $8.91 |
| Revenue Next Year | $7.51 | $6.77 |
| P/E Ratio | $48.13 | ★ $31.89 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $165.60 | $79.93 |
| 52 Week High | $229.24 | $106.33 |
| Indicator | CTAS | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 43.77 | 45.93 |
| Support Level | $165.60 | $85.35 |
| Resistance Level | $188.36 | $89.18 |
| Average True Range (ATR) | 4.53 | 1.58 |
| MACD | 1.09 | 0.56 |
| Stochastic Oscillator | 51.66 | 72.54 |
Cintas has roots dating back to 1929, when the Farmer family cleaned and resold dirty rags to manufacturing plants in Ohio. The firm has expanded its business organically and through acquisitions, and today Cintas acts as a one-stop outsourcing partner for businesses. Cintas will design, manufacture, collect, and clean every employee uniform for a small weekly sum, taking on the upfront capital expense itself. At the same stop, Cintas can also replace soiled or depleted mats, mops, trash liners, towels, first aid supplies, fire extinguishers, and cleaning products. Businesses value an outsourcing partner like Cintas as it simplifies operations and leaves noncore tasks with high regulatory standards in the hands of professionals.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.